InsiderTrades

Form 4 for IRMD IRADIMED CORP

Accepted 2024-10-15 00:00:00 ET · period of report 2024-10-14 · accession 0001415889-24-025137 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-10-15 2024-10-14 IRMD Scharen-Guivel Hilda Frederique Dir M - OptEx — +1,767 3,533 +100% —
D 2024-10-15 2024-10-14 IRMD Scharen-Guivel Hilda Frederique Dir M - OptEx $0.00 -1,767 1,767 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-10-14 M A 1,767 — 3,533 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Derivative Restricted Stock Units 2024-10-14 M D 1,767 $0.00 1,767 D — · 2024-10-14 to — 1,767 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On October 14, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on October 14, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.